(Q44126999)

English

In vitro activities of voriconazole (UK-109, 496), fluconazole, itraconazole and amphotericin B against 132 non-albicans bloodstream yeast isolates (CANARI study).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

In vitro activities of voriconazole (UK-109, 496), fluconazole, itraconazole and amphotericin B against 132 non-albicans bloodstream yeast isolates (CANARI study). (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Swinne D

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Watelle M

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Van der Flaes M

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Nolard N

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

publication date

1 June 2004

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

47

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

5-6

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

177-183

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

The epidemiology of candidemia in two United States cities: results of a population-based active surveillance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2004.00971.X

21 January 2018

Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2004.00971.X

21 January 2018

Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by Broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2004.00971.X

21 January 2018

Increasing incidence of candidemia: results from a 20-year nationwide study in Iceland

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2004.00971.X

21 January 2018

Secular trends of candidemia over 12 years in adult patients at a tertiary care hospital

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2004.00971.X

21 January 2018

Diagnosis and treatment of oropharyngeal candidiasis in patients infected with HIV: a critical reassessment.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2004.00971.X

21 January 2018

Candidemia before and during the fluconazole era: prevalence, type of species and approach to treatment in a tertiary care community hospital

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2004.00971.X

21 January 2018

Prospective, multicenter surveillance study of Candida glabrata: fluconazole and itraconazole susceptibility profiles in bloodstream, invasive, and colonizing strains and differences between isolates from three urban teaching hospitals in New York C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2004.00971.X

21 January 2018

The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2004.00971.X

21 January 2018

Deep Candida infections in the neutropenic and non-neutropenic host: an ISHAM symposium

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2004.00971.X

21 January 2018

Antifungal susceptibility testing of yeasts: evaluation of technical variables for test automation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2004.00971.X

21 January 2018

Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2004.00971.X

21 January 2018

In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2004.00971.X

21 January 2018

In vitro activities of terbinafine in combination with fluconazole, itraconazole, voriconazole, and posaconazole against clinical isolates of Candida glabrata with decreased susceptibility to azoles

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2004.00971.X

21 January 2018

Development of Resistance to Amphotericin B in Candida lusitaniae Infecting a Human

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2004.00971.X

21 January 2018

Saccharomyces cerevisiae infections and antifungal susceptibility studies by colorimetric and broth macrodilution methods.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2004.00971.X

21 January 2018

Aetiology and antifungal susceptibility of yeast bloodstream infections in a Hungarian university hospital between 1996 and 2000.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2004.00971.X

21 January 2018

Identifiers

10.1111/J.1439-0507.2004.00971.X

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44126999&oldid=2106867508"